0000000000141125

AUTHOR

Antonio Giovanni Versace

0000-0001-5021-1365

showing 3 related works from this author

A Strongyloides stercoralis infection presenting as arthritis of sternoclavicular joint

2016

Strongyloides stercoralis (S. stercoralis) is a parasite, endemic in tropical, subtropical, and also not rarely in temperate regions, that infects up to 100 million people worldwide [1]. Patients m...

0301 basic medicinemusculoskeletal diseasesmedicine.medical_specialty030106 microbiologySternoclavicular jointArthritisStrongyloides stercoralis03 medical and health sciences0302 clinical medicineRheumatologyInternal medicineStrongyloidesmedicineReactive arthritis030212 general & internal medicinebiologybusiness.industryArthritismedicine.diseasebiology.organism_classificationhumanitiesRheumatologyStrongyloidiasismedicine.anatomical_structureStrongyloidesImmunologyStrongyloides Arthritis Rheumatologybusinesshuman activities
researchProduct

The COVID-19 Assessment for Survival at Admission (CASA) Index: A 12 Months Observational Study

2021

Objective: Coronavirus disease 2019 (COVID-19) is a disease with a high rate of progression to critical illness. However, the stratification of patients at risk of mortality is not well defined. In this study, we aimed to define a mortality risk index to allocate patients to the appropriate intensity of care.Methods: This is a 12 months observational longitudinal study designed to develop and validate a pragmatic mortality risk score to stratify COVID-19 patients aged ≥18 years and admitted to hospital between March 2020 and March 2021. Main outcome was in-hospital mortality.Results: 244 patients were included in the study (mortality rate 29.9%). The Covid-19 Assessment for Survival at Admi…

Medicine (General)medicine.medical_specialtyLongitudinal studyFramingham Risk ScoreIndex (economics)Respiratory ratebusiness.industryMortality rateCOVID-19DiseaseGeneral Medicinesystemic scorestratification indexR5-920Internal medicinemedicineRisk of mortalityMedicinemortality riskoutcome researchObservational studybusinessOriginal ResearchFrontiers in Medicine
researchProduct

IL-13 and IL-33 Serum Levels Are Increased in Systemic Sclerosis Patients With Interstitial Lung Disease

2022

ObjectiveSystemic sclerosis (SSc) mortality is extremely variable in its internal organ involvement. Pulmonary fibrosis occurs in up to 30% of the cases. Animal models provide evidence that IL-33 is able to induce both cutaneous and pulmonary fibrosis via increased IL-13 and in SSc patients the levels of IL-33 correlate with skin fibrosis. Our aim was to test whether both IL-33 and IL-13 are higher in patients with diffuse SSc and interstitial lung disease (SSc-ILD) compared to SSc patients without ILD and healthy controls.MethodsSerum levels of IL-13 and IL-33 were measured in 30 SSc patients with diffuse disease and 30 healthy controls by enzyme-linked immunosorbent assay. The extent of p…

interstitial lung diseaseMedicine (General)R5-920interleukinsintegumentary systemsystemic sclerosisIL-13IL-13; IL-33; interleukins; interstitial lung disease; systemic sclerosisIL-33General Medicinerespiratory systemskin and connective tissue diseases
researchProduct